Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.04
-0.04-3.7%
Last update: Oct 16, 9:30 AM
$1.09
0.010.93%
CalciMedica Inc (CALC) Stock Price, Quote, News & History
CALCNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of CalciMedica (NASDAQ:CALC) through any online brokerage.
Other companies in CalciMedica’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
CalciMedica has a consensus price target of $74.00.
The stock price for CalciMedica (NASDAQ: CALC) is $1.09 last updated October 16, 2026 at 9:30 AM EDT.
There are no upcoming dividends for CalciMedica.
CalciMedica does not have any upcoming earnings scheduled.
There is no upcoming split for CalciMedica.
CalciMedica is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
